Researchers make miniature 'bone marrows in a dish' to improve anti-cancer treatments

by University of BirminghamA cross section of a mini bone marrow organoids showing cells that produce blood platelets, in a network of blood vessels. Credit: Dr A Khan, University of BirminghamSc

Updated on: February 18,2024

Researchers make miniature 'bone marrows in a dish' to improve anti-cancer treatments

by University of BirminghamA cross section of a mini bone marrow organoids showing cells that produce blood platelets, in a network of blood vessels. Credit: Dr A Khan, University of BirminghamSc

Updated on:February 18,2024

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Updated on: August 28,2024

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Updated on:August 28,2024

Invasive breast cancer risk down for female child cancer survivors

For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 inJAMA Oncology.Tara O. Henderson, M.D., M.P.H., from

Updated on: January 02,2024

Invasive breast cancer risk down for female child cancer survivors

For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 inJAMA Oncology.Tara O. Henderson, M.D., M.P.H., from

Updated on:January 02,2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on: March 30,2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on:March 30,2024

Role of cancer protein ARID1A at intersection of genome stability and tumor suppression

by The Wistar InstituteRugang Zhang, Ph.D., The Wistar Institute. Credit: The Wistar InstituteThe ARID1A tumor suppressor protein is required to maintain telomere cohesion and correct chromosome

Updated on: April 09,2024

Role of cancer protein ARID1A at intersection of genome stability and tumor suppression

by The Wistar InstituteRugang Zhang, Ph.D., The Wistar Institute. Credit: The Wistar InstituteThe ARID1A tumor suppressor protein is required to maintain telomere cohesion and correct chromosome

Updated on:April 09,2024

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on: January 02,2024

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on:January 02,2024

DNA fragments in blood promise cheap, easy test for cancer

by Amy NortonResearchers are reporting progress on a blood test that can detect multiple cancers in a relatively simpler, and potentially less pricey way than other tests under development.The test pi

Updated on: January 15,2024

DNA fragments in blood promise cheap, easy test for cancer

by Amy NortonResearchers are reporting progress on a blood test that can detect multiple cancers in a relatively simpler, and potentially less pricey way than other tests under development.The test pi

Updated on:January 15,2024

Researchers reveal why vaccines have lower efficacy in patients with multiple myeloma

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researc

Updated on: August 28,2024

Researchers reveal why vaccines have lower efficacy in patients with multiple myeloma

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researc

Updated on:August 28,2024

A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

by Harvard Medical SchoolThe Orion tool combines molecular details revealed by immunofluorescence imaging (left) with structural information gained through traditional histology staining (middle)

Updated on: February 24,2024

A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

by Harvard Medical SchoolThe Orion tool combines molecular details revealed by immunofluorescence imaging (left) with structural information gained through traditional histology staining (middle)

Updated on:February 24,2024

Tissue stiffness is a "mosh pit" where cancer cells thrive

by Leslie Orr,University of Rochester Medical CenterCredit: CC0 Public DomainImagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When target

Updated on: March 24,2024

Tissue stiffness is a "mosh pit" where cancer cells thrive

by Leslie Orr,University of Rochester Medical CenterCredit: CC0 Public DomainImagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When target

Updated on:March 24,2024

New study shows more deaths with cancer as contributing cause during first year of pandemic

byAmerican Cancer SocietyACS research in Journal Oncology Practice. Credit: American Cancer SocietyIn a new study, American Cancer Society (ACS) researchers have discovered that deaths with canc

Updated on: January 12,2024

New study shows more deaths with cancer as contributing cause during first year of pandemic

byAmerican Cancer SocietyACS research in Journal Oncology Practice. Credit: American Cancer SocietyIn a new study, American Cancer Society (ACS) researchers have discovered that deaths with canc

Updated on:January 12,2024

Model suggests increased use of Paxlovid could cut hospitalizations, deaths and costs

by University of Texas at AustinEpidemiology researchers have found that if just 20% of symptomatic COVID cases was treated with Paxlovid, it would reduce deaths, hospitalizations and costs. Cred

Updated on: May 06,2024

Model suggests increased use of Paxlovid could cut hospitalizations, deaths and costs

by University of Texas at AustinEpidemiology researchers have found that if just 20% of symptomatic COVID cases was treated with Paxlovid, it would reduce deaths, hospitalizations and costs. Cred

Updated on:May 06,2024